Cooperative Agreement 2412634
Award Date
8/15/24
Completion Date
7/31/26
Dollars Obligated
$983K
Federal Agency
National Science Foundation
Awardee
Quadralynx Inc. (C2RUB9FQ45C9)
Federal Grant Program
47.084
Assistance Type
Cooperative Agreement
Place of Performance
Spokane, WA 99202, USA
Similar Awards
The National Science Foundation awarded Quadralynx Inc. a $255,750 Project Grant under the NSF Technology, Innovation, and Partnerships program (CFDA 47.084) to develop a biofeedback system for adults with Parkinson's disease. The grant period runs from December 15, 2021 through July 31, 2022 in Spokane, Washington. Under this award, Quadralynx will deliver a biofeedback system utilizing sensors and software to help adults with Parkinson's disease improve motor function through interactive...
This National Science Foundation (NSF) Cooperative Agreement award, under the Technology, Innovation, and Partnerships (TIP) program (CFDA 47.084), provides $999,988 in funding to Dasion Corporation to develop a healthcare technology platform that utilizes geometric unified learning. The platform aims to enhance the efficiency and accuracy of healthcare diagnostics and monitoring, particularly for diseases that can be diagnosed and monitored using data sources like voice and EEG. The project...
This Project Grant award, provided by the National Science Foundation (NSF) under the Technology, Innovation, and Partnerships (TIP) program (CFDA 47.084), supports the development of the SonoVoice Voice Evaluation and Monitoring System. The $275,000 award, effective from September 15, 2024 to August 31, 2025, will be used by the small business Sonovoice, Inc. to create an affordable, portable digital device and smartphone application for comprehensive voice health evaluations. The proposed...
This $999,994 cooperative agreement from the National Science Foundation under the Technology, Innovation, and Partnerships program will support Deepconvo Inc.'s development of voice-based telehealth products and services for respiratory disease monitoring and screening. Deepconvo will further develop its chronic obstructive pulmonary disease early exacerbation warning system to more accurately measure lung function deterioration through voice and breath data captured on mobile phones. Key...
This $997,735 cooperative agreement from the National Science Foundation will support Neurotechr3 Inc.'s development of a personalized telerehabilitation solution for individuals recovering from stroke-related arm and hand impairments. The awardee will advance its machine learning-driven telerehabilitation system through new exergames, personalized rehabilitation plans synchronized with patient recovery trajectories, and clinical evaluations. The system aims to improve access to effective...
This National Science Foundation (NSF) Cooperative Agreement award under the NSF Technology, Innovation, and Partnerships (TIP) program (CFDA 47.084) provides $959,066 in funding to Jelikalite Corp. to develop a non-invasive therapeutic brain stimulation medical device to improve communication, responsiveness, and social integration for autistic children. The project aims to finalize a prototype device that delivers transcranial photobiomodulation (TPBM) therapy based on integrated...
This $997,693 Cooperative Agreement awarded by the National Science Foundation (NSF) under the Technology, Innovation, and Partnerships (CFDA 47.084) program aims to develop an interactive health assessment and monitoring platform to improve patient-provider communication and reduce healthcare costs. The project by Literaseed, Inc. integrates electronic health record (EHR) data with natural language processing (NLP) techniques to extract valuable information from medical records, enabling...
This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Project Grant award of $275,000 to Brainstorm Therapeutics, Inc. aims to develop and validate a novel Parkinson's disease drug discovery platform using patient-derived midbrain organoids. The platform will guide therapeutic candidate identification, patient selection, and trial endpoint refinement to accelerate the development of effective disease-modifying Parkinson's treatments. Key innovations...
This National Science Foundation (NSF) award under the Computer and Information Science and Engineering (CFDA 47.070) program provides $285,274 to Oregon Health & Science University (OHSU) to develop and test new technology that will enhance communication and interaction for individuals with severe speech and motor impairments. The project aims to create a novel interface that leverages multiple information sources, such as eye gaze, language models, behavioral patterns, and sequences of...
This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Project Grant award provides $303,226 to develop an innovative AI-driven platform for personalized language learning activities for young children with communication delays. The key products and services to be delivered under this award include: Creating a robust framework for speech pattern analysis using machine learning techniques to achieve high accuracy in speech recognition across diverse...